Across TCGA pan-cancer cohorts, GAGE12E RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated GAGE12E data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher GAGE12E RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAGE12E expression acts as an unfavorable survival marker.
BLCA, STAD, and SKCM are the cancer types where GAGE12E RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.